SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021605
Filing Date
2020-08-12
Accepted
2020-08-12 16:02:33
Documents
91
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_immucellcorp.htm 10-Q 1079614
2 CERTIFICATION f10q0620ex31_immucell.htm EX-31 6670
3 CERTIFICATION f10q0620ex32_immucell.htm EX-32 4225
  Complete submission text file 0001213900-20-021605.txt   6257246

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20200630.xml EX-101.INS 1393034
5 XBRL SCHEMA FILE iccc-20200630.xsd EX-101.SCH 60430
6 XBRL CALCULATION FILE iccc-20200630_cal.xml EX-101.CAL 66033
7 XBRL DEFINITION FILE iccc-20200630_def.xml EX-101.DEF 176110
8 XBRL LABEL FILE iccc-20200630_lab.xml EX-101.LAB 426339
9 XBRL PRESENTATION FILE iccc-20200630_pre.xml EX-101.PRE 326566
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 201095446
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences